HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing a pipeline of lncRNA-targeting candidates for the cell-specific treatment of diseases in other tissues, including the lungs and the microenvironment of solid tumor cancers. Headquartered at the life sciences park Biopôle in Lausanne, Switzerland with laboratory facilities at JLABS @ San Diego, HAYA is led by a world-class team of experts in programmable and precision RNA-targeted therapeutics and is supported by a strong investor consortium. HAYA’s mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility than existing treatments. 

Biotechnology

Life Sciences

Therapeutics

HAYA Therapeutics

Samir Ounzain

Dmitry Kopelyanskiy

María Marcuello

James Karras

The Research and Development Team at HAYA Therapeutics is responsible for advancing the company's innovative cell-state modifying platform to explore and understand the biology of long non-coding RNAs (lncRNAs) and their potential therapeutic applications. This team carries out experiments, conducts functional genomic studies, and develops targeted antisense oligonucleotide-based therapies, including the lead candidate HTX-001. They work collaboratively to expand the pipeline of lncRNA-targeting candidates for treating serious diseases such as cardiovascular conditions, lung ailments, and various cancers, with the ultimate goal of creating safer and more effective precision medicines.

Research and Development Team

Bioinformatics & Computational Biology

Research and Development Team

About

Team members

Other teams at HAYA Therapeutics

Bioinformatics & Computational Biology